Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Neoplasia (New York, N.Y.)|March 13, 2013
HMGA2 inhibits apoptosis through interaction with ATR-CHK1 signaling complex in human cancer cellsSuchitra Natarajan, Sabine Hombach-Klonisch, Peter Dröge, et al.
Frontiers in Endocrinology|April 12, 2014
Mechanisms of therapeutic resistance in cancer (stem) cells with emphasis on thyroid cancer cellsSabine Hombach-Klonisch, Suchitra Natarajan, Thatchawan Thanasupawat, et al.
Thyroid : Official Journal of the American Thyroid Association|July 4, 2013
Three-dimensional telomere dynamics in follicular thyroid cancerLandon Wark, Adrian Danescu, Suchitra Natarajan, et al.
Oncotarget|January 23, 2016
High Mobility Group A2 protects cancer cells against telomere dysfunctionSuchitra Natarajan, Farhana Begum, Jeonga Gim, et al.
Cell Reports|February 11, 2014
Chaperoning HMGA2 protein protects stalled replication forks in stem and cancer cellsHaojie Yu, Hong Hwa Lim, Natalia O Tjokro, et al.
Molecular Oncology|October 28, 2025
In vitro models of cancer-associated fibroblast heterogeneity uncover subtype-specific effects of CRISPR perturbationsElysia Saputra, Shamsudheen Karuthedath Vellarikkal, Lixia Li, et al.
Molecular Oncology|May 14, 2017
Dovitinib enhances temozolomide efficacy in glioblastoma cellsThatchawan Thanasupawat, Suchitra Natarajan, Amy Rommel, et al.
Molecular Oncology|October 6, 2018
HMGA2 as a functional antagonist of PARP1 inhibitors in tumor cellsSabine Hombach-Klonisch, Forouh Kalantari, Manoj Reddy Medapati, et al.
Molecular Cancer Therapeutics|December 6, 2021
Abdominopelvic FLASH Irradiation Improves PD-1 Immune Checkpoint Inhibition in Preclinical Models of Ovarian CancerJoshua T Eggold, Stephanie Chow, Stavros Melemenidis, et al.
The Journal of Clinical Investigation|August 16, 2021
Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signalingJin Qian, Bauer L LeSavage, Kelsea M Hubka, et al.
Pageof 2